Incidence of Intracranial Melanoma Progression in the Setting of Positive Extracranial Response to Targeted Therapy and Immunotherapy: An Indication for More Frequent Screening in This Population?

Background and objective The incidence of intracranial metastases from melanoma is on the rise. In this study, we aimed to determine the incidence of intracranial disease progression in patients on BRAF/MEK targeted therapy and immunotherapy in the setting of controlled or improving extracranial dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gattozzi, Domenico A, Rosso, Casey, Schatmeyer, Bryan A, Kabangu, Jean-Luc K, Doolittle, Gary C, Wang, Fen, Stepp, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013837/
https://www.ncbi.nlm.nih.gov/pubmed/33824801
http://dx.doi.org/10.7759/cureus.13648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013837/
https://www.ncbi.nlm.nih.gov/pubmed/33824801
http://dx.doi.org/10.7759/cureus.13648

Ejemplares similares